Qube Research & Technologies LTD Anika Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
A detailed history of Qube Research & Technologies LTD transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 42,564 shares of ANIK stock, worth $481,398. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,564
Previous 48,737
12.67%
Holding current value
$481,398
Previous $802,000
20.32%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ANIK
# of Institutions
107Shares Held
11.3MCall Options Held
1.2KPut Options Held
1.4K-
Trigran Investments, Inc.2.04MShares$23.1 Million5.01% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$18.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA777KShares$8.79 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX614KShares$6.94 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA540KShares$6.1 Million0.02% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $165M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...